Skip to main content
  • What are you looking for?

Robin Carhart-Harris, Head of Centre for Psychedelic Research, Imperial College London

Robin Carhart-Harris is a psychologist and neuroscientist at Imperial College London who heads their Centre for Psychedelic Research, which he founded in 2019—the first of its kind in the world.

Robin is the first scientist in more than 40 years to successfully coordinate clinical studies on humans of classic psychedelics, including psilocybin and LSD.

Over the last four years at Imperial College, Robin has designed (with Professor David Nutt) human brain imaging studies with LSD, psilocybin, MDMA, and DMT. He's also conducted a clinical trial of psilocybin for treatment-resistant depression; an ongoing trial comparing psilocybin with escitalopram for major depressive disorder; and a multimodal imaging study in healthy volunteers receiving psilocybin for the first time.

Robin has a review article published in Brain on the neurobiology of Freudian constructs and his work with psilocybin is now published in Proceedings of the National Academy of Sciences (PNAS), The British Journal of Psychiatry (BJPsych), and Frontiers in Human Neuroscience, with other relevant papers forthcoming.

He has been supported by the Beckley Foundation, the Neuropsychoanalysis Foundation, the Heffter Research Institute, and the Multidisciplinary Association for Psychedelic Studies (MAPS), and holds an honorary position with the University of Oxford.

Current Program


Upcoming Program


Past Program